Cite
MLA Citation
Richard Pratley et al.. “Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial.” Lancet, vol. 394, no. 10192, 2019, pp. 39–50. http://access.bl.uk/ark:/81055/vdc_100086830526.0x000045